VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease... Show more
The Stochastic Oscillator for VPTDF moved out of overbought territory on June 25, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 59 similar instances where the indicator exited the overbought zone. In of the 59 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on June 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VPTDF as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for VPTDF turned negative on July 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
The 50-day moving average for VPTDF moved below the 200-day moving average on June 05, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VPTDF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
VPTDF broke above its upper Bollinger Band on June 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VPTDF entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
VPTDF moved above its 50-day moving average on July 01, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VPTDF crossed bullishly above the 50-day moving average on June 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VPTDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VPTDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.006) is normal, around the industry mean (24.504). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. VPTDF's P/S Ratio (1000.000) is very high in comparison to the industry average of (43.111).
Industry MedicalSpecialties
A.I.dvisor tells us that VPTDF and VNRX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VPTDF and VNRX's prices will move in lockstep.
Ticker / NAME | Correlation To VPTDF | 1D Price Change % | ||
---|---|---|---|---|
VPTDF | 100% | -6.38% | ||
VNRX - VPTDF | 20% Poorly correlated | -1.53% | ||
OM - VPTDF | 10% Poorly correlated | +1.55% | ||
XVIPF - VPTDF | 7% Poorly correlated | N/A | ||
WILLF - VPTDF | 5% Poorly correlated | N/A | ||
ZTEK - VPTDF | 5% Poorly correlated | +3.74% | ||
More |